CareDx, Inc.: STATE STREET CORP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
State Street Corp. disclosed a stake exceeding 5% in CareDx, Inc. via a Schedule 13G filing with the SEC (accession 0000093751-26-000627). The filing signals that the institutional investor has crossed the key 5% beneficial ownership threshold in the transplant diagnostics company. Such 13G disclosures are typically passive holdings and can draw attention from other institutional investors tracking ownership changes. CareDx investors will watch for further stake updates and any shifts in institutional ownership in upcoming filings.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
State Street Corp, CareDx, Inc.